Abstract
Despite advances in drug treatments, multiple myeloma almost always remains a fatal disease. Technical advances in radiotherapy enable total marrow irradiation (TMI) by intensity-modulated radiation therapy (IMRT) to better protect healthy tissues and organs. This therapeutic modality can be proposed in conditioning for an autograft of peripheral stem cells (PSC). The purpose of this chapter is to report the French experience in first-recurrence multiple myeloma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moreau P, de Wit E. Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions. Br J Haematol. 2017;179(2):198–218. https://doi.org/10.1111/bjh.14780. Epub 2017 May 30.
Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F, et al. Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe francophone du Myélome 9502 randomized trial. Blood. 2002;99:731–5.
Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GE, et al. Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood. 2003;101(6):2144–51. Epub 2002 Nov 27.
Bladé J, Rosiñol L, Sureda A, Ribera JM, Díaz-Mediavilla J, García-Laraña J, et al. High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA. Blood. 2005;106(12):3755–9. Epub 2005 Aug 16.
Wong JY, Liu A, Schultheiss T, Popplewell L, Stein A, Rosenthal J, et al. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation. Biol Blood Marrow Transplant. 2006;12:306–15.
Wong JY, Rosenthal J, Liu A, Schultheiss T, Forman S, Somlo G. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys. 2009;73(1):273–9. https://doi.org/10.1016/j.ijrobp.2008.04.071. Epub 2008 Sep 9.
Somlo G, Spielberger R, Frankel P, Karanes C, Krishnan A, Parker P, et al. Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma. Clin Cancer Res. 2011;17:174–82. https://doi.org/10.1158/1078-0432.CCR-10-1912. Epub 2010 Nov 3.
Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J. Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2018;101(4):794–808. https://doi.org/10.1016/j.ijrobp.2018.05.009. Epub 2018 Jun 20. Review. Erratum in: Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1602. PubMed PMID: 29976492.
Zeverino M, Agostinelli S, Taccini G, Cavagnetto F, Garelli S, Gusinu M, et al. Advances in the implementation of helical tomotherapy-based total marrow irradiation with a novel field junction technique. Med Dosim. 2012;37(3):314–20. https://doi.org/10.1016/j.meddos.2011.12.001. Epub 2012 Feb 10.
Shueng PW, Lin SC, Chong NS, Lee HY, Tien HJ, Wu LJ, et al. Total marrow irradiation with helical tomotherapy for bone marrow transplantation of multiple myeloma: first experience in Asia. Technol Cancer Res Treat. 2009;8:29–38.
Lin SC, Hsieh PY, Shueng PW, Tien HJ, Wang LY, Hsieh CH. Total marrow irradiation as part of autologous stem cell transplantation for Asian patients with multiple myeloma. Biomed Res Int. 2013;2013:321762. https://doi.org/10.1155/2013/321762. Epub 2013 Sep 8.
Patel P, Oh AL, Koshy M, Sweiss K, Saraf SL, Quigley JG, et al. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018;59(7):1666–71. https://doi.org/10.1080/10428194.2017.1390231. Epub 2017 Oct 25.
Zaucha RE, Buckner DC, Barnett T, Holmberg LA, Gooley T, Hooper HA, et al. Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies. Int J Radiat Oncol Biol Phys. 2006;64(1):227–34. Epub 2005 Sep 19.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mahé, M.A. et al. (2020). Total Marrow Irradiation in Multiple Myeloma: The French Myeloma Group Experience. In: Wong, J., Hui, S. (eds) Total Marrow Irradiation. Springer, Cham. https://doi.org/10.1007/978-3-030-38692-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-38692-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-38691-7
Online ISBN: 978-3-030-38692-4
eBook Packages: MedicineMedicine (R0)